Phorbol Ester Stroke Treatment Modulating PKC Signaling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for stroke are inadequate, with high mortality and morbidity rates, and existing pharmaceutical agents like phorbol esters face challenges due to toxicity and limited effectiveness in managing inflammatory reactions associated with stroke.
Innovation Solution
Compositions and methods utilizing phorbol esters and their derivatives, specifically 12-O-tetradecanoylphorbol-13-acetate (TPA), to modulate cell signaling pathways, alter cytokine release, and treat or prevent stroke-related symptoms such as paralysis, memory loss, and cognitive impairment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If phorbol esters are used to activate protein kinase C and modulate cell signaling pathways, then the ability to treat stroke and improve cognitive function is enhanced, but toxicity and inflammatory reactions worsen
Solution Approach 1:
The patent applies this principle by utilizing the inflammatory and immune-stimulating properties of phorbol esters, which were traditionally considered harmful side effects, as therapeutic mechanisms to treat stroke. The compound promotes neuroprotection and cognitive recovery by leveraging these previously unwanted biological responses.
Solution Approach 2:
The patent employs parameter changes by modifying the chemical structure of phorbol esters to create derivatives with altered potency and selectivity. This allows optimization of the therapeutic window, enhancing stroke treatment effectiveness while reducing toxic effects and inflammatory reactions.
2Adaptability or versatility
If plant-based compounds are used for medicinal purposes, then the ability to treat various conditions is enhanced, but isolation and commercialization become more difficult
Solution Approach 1:
The patent applies this principle by isolating and purifying the active phorbol ester compounds from their plant sources. This extraction process separates the therapeutically active components from the complex plant matrix, enabling standardized production and commercialization while maintaining medicinal effectiveness.
Solution Approach 2:
The patent applies this principle by focusing on specific active compounds within the plant rather than using whole plant extracts. This targeted approach to isolating particular phorbol ester derivatives with proven stroke treatment benefits enables more consistent quality control and easier commercialization compared to broad-spectrum plant extracts.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of phorbol esters effectively reduces the severity and frequency of stroke symptoms, decreases the risk of subsequent strokes, and improves cognitive and motor functions, offering a novel approach to managing stroke and its sequelae.
Implementation Method 1
Phorbol esters have important biological properties including the reported ability to mimic diacylglycerols and activate protein kinase C (PKC)
Data Source
AI summary
Methods and compositions containing a phorbol ester or a derivative of a phorbol ester are provided for the treatment and prevention of stroke and the sequelae of stroke. Additional compositions and methods are provided which employ a phorbol ester or derivative compound in combination with at least one additional agent to yield more effective treatment tools to treat or prevent stroke and the long term effects of stroke in mammalian subjects.